Keywords: merck, s-p, file, usa, cholesterol, drug, co
Merck, S-P file in USA for cholesterol drug
Article | 07 January 2002
Merck & Co and Schering-Plough have submitted a marketing application inthe USA for Zetia (ezetimibe), a cholesterol-absorption inhibitor discovered by S-P ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
